Hesitant or not? A global survey of potential acceptance of a COVID-19 vaccine
Lazarus, J. V.; Ratzan, S.; Palayew, A.; Gostin, L. O.; Larson, H. J.; Rabin, K.; Kimball, S.; El-Mohandes, A.
Show abstract
A number of COVID-19 vaccines are under development, with one or more possibly becoming available in 2021. We conducted a global survey in June 2020 of 13,426 people in 19 countries to determine potential acceptance rates of a COVID-19 vaccine and factors influencing acceptance. We ran univariate logistic regressions to examine the associations with demographic variables. 71.5% reported they would be very or somewhat likely to take a COVID-19 vaccine; 61.4% reported they would accept their employers recommendation to take a COVID-19 vaccine. Differences in acceptance across countries ranged from almost 9 in 10 (China) to fewer than 6 in 10 (Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine, and take their employers advice to do so. Targeted interventions addressing age, sex, income, and education level are required to increase and sustain public acceptance of a COVID-19 vaccine.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.